Table 1.
The expert panel (n = 8) that collaboratively determined the scope and design of the review, and interpreted its findings.
Fig 1.
PRISMA flow diagram of the identification of eligible studies.
Fig 2.
Mapping the available evidence: Total articles summarized by reliability and convergent validity.
Fig 3.
Number of studies with “acceptable” convergent validity (e.g. reported ICC > 0.70), that were “not acceptable” (e.g. reported ICC < 0.70), or “inconclusive” (e.g. reported statistics incomplete) for each of the most commonly evaluated assessment tools (whole-body and regional studies combined).
Table 2.
Data charting (extraction) of eligible studies in alphabetical order by first author.
Table 3.
Future priorities and considerations for research on measurement properties of body composition in the SCI population.